Apollo Ingredients (BSE 503639)₹95.00−3.55%Diversified Commercial Services
In the Mar 2026 quarter (standalone), Apollo Ingredients reported sales of ₹1 Cr, up 42.9% from Mar 2025, and net profit of ₹0.08 Cr, down 52.9% year on year. For the year to Mar 2026, sales were ₹4.89 Cr and net profit ₹0.72 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 1.01 | 0.51 | 0.81 | 1.10 | 0.70 | 0.55 | 0.58 | 2.76 | 1.00 |
| Expenses | 0.06 | 0.04 | 0.04 | 0.81 | 0.51 | 1.00 | 0.96 | 0.54 | 0.68 | 0.56 | 1.91 | 0.92 |
| Operating Profit | −0.04 | −0.02 | −0.02 | 0.19 | 0.00 | −0.18 | 0.13 | 0.15 | −0.10 | 0.01 | 0.86 | 0.09 |
| OPM % | — | — | — | 20.0% | 0.0% | −23.8% | 12.8% | 23.2% | −19.7% | 3.5% | 31.4% | 9.9% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 |
| Profit before tax | −0.04 | −0.02 | −0.02 | 0.19 | 0.00 | −0.18 | 0.13 | 0.15 | −0.10 | 0.01 | 0.86 | 0.06 |
| Tax % | 0.0% | 0.0% | 0.0% | 10.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −0.06 | −0.04 | −0.04 | 0.18 | 0.00 | −0.20 | 0.15 | 0.17 | −0.12 | 0.03 | 0.88 | 0.08 |
| EPS (Rs) | −0.04 | −0.02 | −0.02 | 0.15 | 0.00 | −0.17 | 0.12 | 0.14 | −0.10 | 0.01 | 0.83 | 0.06 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 4.35 | 4.57 | 2.36 | 0.00 | 1.01 | 3.08 | 4.89 | 4.89 |
| Expenses | 0.18 | 0.18 | 0.18 | 0.18 | 4.27 | 4.46 | 2.42 | 0.11 | 0.93 | 2.96 | 3.99 | 4.07 |
| Operating Profit | −0.16 | −0.16 | −0.16 | −0.16 | 0.07 | 0.12 | −0.03 | −0.09 | 0.07 | 0.11 | 0.91 | 0.86 |
| OPM % | — | — | — | — | 1.8% | 2.8% | −1.7% | — | 8.0% | 3.9% | 18.8% | 17.6% |
| Other Income | 0.11 | 0.11 | 0.10 | 0.09 | 0.10 | 0.13 | 0.11 | 0.02 | 0.00 | 0.00 | 0.12 | 0.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.11 |
| Profit before tax | −0.04 | −0.04 | −0.05 | −0.06 | 0.18 | 0.26 | 0.07 | −0.06 | 0.07 | 0.12 | 0.94 | 0.83 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 15.8% | 22.2% | 25.1% | 0.0% | 25.0% | 23.1% | 26.4% | — |
| Net Profit | −0.06 | −0.06 | −0.07 | −0.08 | 0.17 | 0.22 | 0.07 | −0.08 | 0.07 | 0.11 | 0.72 | 0.87 |
| EPS (Rs) | — | — | — | — | — | — | 0.05 | −0.06 | 0.05 | 0.09 | 0.67 | 0.80 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.20 | 5.21 |
| Reserves | 1.01 | 0.96 | 0.69 | 0.63 | 0.56 | 0.72 | 0.93 | 0.99 | 0.92 | 0.99 | 1.08 | 1.80 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
| Other Liabilities | 0.20 | 0.01 | 0.01 | 0.01 | 0.01 | 0.10 | 0.01 | 0.02 | 0.04 | 0.53 | 0.39 | 0.20 |
| Total Liabilities | 1.42 | 1.18 | 0.91 | 0.85 | 0.78 | 1.03 | 1.15 | 1.22 | 1.17 | 1.73 | 1.68 | 7.25 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.91 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.22 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1.20 | 0.96 | 0.91 | 0.85 | 0.78 | 1.03 | 1.15 | 1.22 | 1.17 | 1.73 | 1.68 | 4.34 |
| Trade receivables | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.56 |
| Cash & equivalents | — | 0.01 | 0.01 | 0.01 | 0.00 | 0.11 | 0.07 | 0.07 | 0.22 | 1.67 | 1.55 | 3.64 |
| Total Assets | 1.42 | 1.18 | 0.91 | 0.85 | 0.78 | 1.03 | 1.15 | 1.22 | 1.17 | 1.73 | 1.68 | 7.25 |
| Mar 2015 | Mar 2016 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.02 | 0.02 | 0.00 | 0.12 | −0.05 | 0.02 | 0.11 | 1.46 | −0.13 | 0.10 |
| Cash from investing activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −3.01 |
| Cash from financing activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.99 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.10 | −0.03 | 0.00 | 0.10 | 1.46 | −0.11 | 2.08 |
| Capex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 |
| Free cash flow | −0.02 | 0.02 | −0.02 | 0.12 | −0.05 | 0.02 | 0.11 | 1.48 | −0.13 | −2.92 |
| CFO / OP % | 9.0% | −6.0% | 6.0% | 175.0% | 15.0% | −75.0% | −100.0% | 1,838.0% | −75.0% | 37.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | — | — | — | — | 0 | 0 | 0 | — | 0 | 13 | 42 |
| Inventory days | 0 | — | — | — | — | 0 | 0 | 0 | — | 0 | 0 | 0 |
| Cash conversion cycle | 0 | — | — | — | — | 0 | 0 | 0 | — | 0 | 14 | 43 |
| Working capital days | 893 | — | — | — | — | 65 | 82 | 165 | — | −165 | −35 | 32 |
| ROCE % | 6.6% | −4.3% | −4.9% | −7.0% | −8.9% | 22.6% | 26.3% | 6.9% | −6.1% | 6.9% | 10.5% | 22.8% |
For the Mar 2026 quarter, Apollo Ingredients reported sales of ₹1 Cr, up 42.9% year on year and net profit of ₹0.08 Cr, down 52.9% year on year. The operating margin was 9.9%.
Apollo Ingredients' sales for the year to Mar 2026 were ₹4.89 Cr; over the last twelve months they were ₹4.89 Cr.
Net profit for the year to Mar 2026 was ₹0.72 Cr, and ₹0.87 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.80.
Apollo Ingredients reported borrowings of ₹0.04 Cr at Mar 2026, against cash and equivalents of ₹3.64 Cr.
Cash from operations was ₹0.10 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹2.92 Cr.